Evidence map›Paper›PMID 33866473›Full record

Observational studyAnnals of surgical oncology2021

Is Re-introducing Major Open and Minimally Invasive Surgery during COVID-19 Safe for Patients and Healthcare Workers? An International, Multi-centre Cohort Study in the Field of Oesophago-gastric Surgery.

Mohamed Alasmar, Afsana Kausar, Alexander Berend-Jan Borgstein, Johnny Moons, Sophie Doran, Stefano de Pascale, Rafael Restrepo, Apollonia Verrengia, Mariella Alloggio, Ana Moro Delgado and 12 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Annals of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. [Impact of COVID-19 on oncological surgery of the upper gastrointestinal tract].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2021
    Guideline
  2. Article
  3. Article
  4. Article
  5. Don't Let a Crisis Go to Waste.Annals of surgical oncology · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Mohamed AlasmarDepartment of Oesophago-Gastric Surgery, Salford Royal NHS Foundation Trust, Salford Royal Hospital, Manchester, UK.
Afsana KausarDepartment of Oesophago-Gastric Surgery, Salford Royal NHS Foundation Trust, Salford Royal Hospital, Manchester, UK.
Alexander Berend-Jan BorgsteinDepartment of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Johnny MoonsDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
Sophie DoranDepartment of Academic Surgery, Royal Marsden NHS Foundation Trust, London, UK.
Stefano de PascaleIstituto Europeo di Oncologia - IRCCS, Milan, Italy.
Rafael RestrepoHospital Universitario Fundación Jiménez Diaz, Madrid, Spain.
Apollonia VerrengiaDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Mariella AlloggioUniversity of Verona, Verona, Italy.
Ana Moro DelgadoBasurto University Hospital, Bilbao, Spain.
Sacheen KumarDepartment of Academic Surgery, Royal Marsden NHS Foundation Trust, London, UK.
Ismael Díez Del ValBasurto University Hospital, Bilbao, Spain.
Simone GiocapuzziUniversity of Verona, Verona, Italy.
Gian Luca BaiocchiDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Marta de Vega IrañetaHospital Universitario Fuenlabrada, Madrid, Spain.
Gabriel SalcedoHospital Universitario Fundación Jiménez Diaz, Madrid, Spain.
Peter VorwaldHospital Universitario Fundación Jiménez Diaz, Madrid, Spain.
Uberto Fumagalli RomarioIstituto Europeo di Oncologia - IRCCS, Milan, Italy.
Philippe NafteuxDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
Suzanne GisbertzDepartment of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Mohammed Asif ChaudryDepartment of Academic Surgery, Royal Marsden NHS Foundation Trust, London, UK.
Bilal AlkhaffafDepartment of Oesophago-Gastric Surgery, Salford Royal NHS Foundation Trust, Salford Royal Hospital, Manchester, UK. bilal.alkhaffaf@srft.nhs.uk.ORCID http://orcid.org/0000-0001-5751-1846

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic has resulted in unparalleled changes to patient care, including the suspension of cancer surgery. Concerns regarding COVID-19-related risks to patients and healthcare workers with the re-introduction of major complex minimally invasive and open surgery have been raised. This study examines the COVID-19 related risks to patients and healthcare workers following the re-introduction of major oesophago-gastric (EG) surgery. PATIENTS AND

methodsThis was an international, multi-centre, observational study of consecutive patients treated by open and minimally invasive oesophagectomy and gastrectomy for malignant or benign disease. Patients were recruited from nine European centres serving regions with a high population incidence of COVID-19 between 1 May and 1 July 2020. The primary endpoint was 30-day COVID-19-related mortality. All staff involved in the operative care of patients were invited to complete a health-related survey to assess the incidence of COVID-19 in this group.

resultsIn total, 158 patients were included in the study (71 oesophagectomy, 82 gastrectomy). Overall, 87 patients (57%) underwent MIS (59 oesophagectomy, 28 gastrectomy). A total of 403 staff were eligible for inclusion, of whom 313 (78%) completed the health survey. Approaches to mitigate against the risks of COVID-19 for patients and staff varied amongst centres. No patients developed COVID-19 in the post-operative period. Two healthcare workers developed self-limiting COVID-19.

conclusionsPrecautions to minimise the risk of COVID-19 infection have enabled the safe re-introduction of minimally invasive and open EG surgery for both patients and staff. Further studies are necessary to determine the minimum requirements for mitigations against COVID-19.

Indexed as

COVID-19PandemicsHealth PersonnelHumansMinimally Invasive Surgical ProceduresSARS-CoV-2

Identifiers

PMID33866473
PMCPMC8053024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.